SEC Form 4 · accession 0001070081-18-000087
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephanie Okey
Director
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 8:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F1 | $33.63 | Dec 14, 2018 | A | 14,000 | A | — | Dec 13, 2028 | Common Stock | 14,000 | 14,000 | D |
| Stock Option (Right To Buy) | $33.63 | Dec 14, 2018 | A | 1,167 | A | Jan 3, 2019 | Dec 13, 2028 | Common Stock | 1,167 | 1,167 | D |
Explanation of responses
- F1This option award vests in thirty-six approximately equal monthly installments, commencing on January 14, 2019 and continuing on each successive monthly anniversary of thereafter, ending on the third year anniversary of the grant date.